- People
- Offices
- Capabilities
back- Capabilities
- Corporate, Finance and Investments
- back
- Corporate, Finance and Investments
- Overview
- Activist Defense
- Alternative Capital and Credit Funds
- Capital Markets
- Construction and Procurement
- Corporate Governance
- Emerging Companies and Venture Capital
- Employee Benefits and Executive Compensation
- Energy and Infrastructure Projects
- Financial Restructuring
- Investment Funds and Asset Management
- Leveraged Finance
- Mergers and Acquisitions
- Middle East and Islamic Finance and Investment
- Private Equity
- Real Estate
- Securitization
- Tax
- Technology Transactions
- Government Matters
- back
- Government Matters
- Overview
- Antitrust
- Data, Privacy and Security
- Environmental, Health and Safety
- FDA and Life Sciences
- Government Advocacy and Public Policy
- Government Contracts
- Healthcare
- International Trade
- National Security and Corporate Espionage
- Securities Enforcement and Regulation
- Special Matters and Government Investigations
- Trial and Global Disputes
- back
- Trial and Global Disputes
- Overview
- Appellate, Constitutional and Administrative Law
- Bankruptcy and Insolvency Litigation
- Class Action Defense
- Commercial Litigation
- Construction and Engineering Disputes
- Corporate and Securities Litigation
- E-Discovery
- Insurance Coverage and Recovery
- Intellectual Property, Patent, Trademark and Copyright Litigation
- International Arbitration and Litigation
- Labor and Employment
- Product Liability
- Professional Liability
- Toxic & Environmental Torts
- Industries / Issues
- Careers
- News & Insights
- About
- Languages
Brian A. Bohnenkamp
Insight 15 results
Client Alert
October 17, 2019
HHS Issues Proposed Rule to Update Anti-Kickback Statute Safe Harbors – What Does it Mean for Life Sciences Companies?
Client Alert
May 14, 2019
CMS Issues Final Rule Requiring the Disclosure of Drug List Prices in Direct-to-Consumer Television Ads
Client Alert
April 22, 2019
Congress Acts to Eliminate MDRP Misclassification
Client Alert
February 4, 2019
HHS Proposes Rule Challenging Drug Manufacturer Rebates to PBMs and Payors
Client Alert
January 9, 2019
AdvaMed Updates Code of Ethics on Interactions with U.S. Health Care Professionals
Client Alert
May 14, 2018
Trump Administration Releases 'Blueprint' to Address Drug Prices
Client Alert
February 8, 2018
2017 Year in Review: State Laws Target Pharma Manufacturers
Client Alert
April 21, 2017
New York Institutes New Medicaid Drug Price Control Measures
Client Alert
December 14, 2016
OIG Issues Final Rule Expanding Anti-Kickback Statute Safe Harbors and Revising Civil Monetary Penalty Regulations
Client Alert
August 25, 2015
OIG Issues Advisory Opinion Regarding Pharmaceutical Manufacturer Free Drug Program
Newsletter
December 22, 2014
Health Headlines – December 22, 2014
Newsletter
October 6, 2014
Health Headlines – October 6, 2014